SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-031802
Filing Date
2021-12-17
Accepted
2021-12-17 07:39:22
Documents
13
Period of Report
2021-12-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38289
2 ex99-1.htm EX-99.1 109807
  Complete submission text file 0001493152-21-031802.txt   332842

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sonn-20211217.xsd EX-101.SCH 3028
4 XBRL LABEL FILE sonn-20211217_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE sonn-20211217_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3616
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 211499513
SIC: 2834 Pharmaceutical Preparations